02.02.2019 Issue 157

   
Visit HealthEconomics.Com Subscribe to Newsletters  |  Contact Us  |  Forward to a Friend
Sponsored by:

This Week's HEOR Jobs Round-up
Job of the Week Latest Jobs from the Jobs Portal

Sr. Director, Health Economics
and Outcomes Research

The Sr. Director of Global HEOR will play a critical and significant role in the growth of Akcea as an organization and in the successful commercialization of Waylivra™ (volanesorsen), Tegsedi™ (inotersen) and our pipeline products.

Director, HEOR (Southeast)

Global Health Economics Senior Manager

Health Economics Senior Manager

Global Health Economics Senior Manager

Bus Info Developer Consultant Senior-PS15823

Provider Contract/Cost of Care Analyst Sr or Consultant - PS16806

Researcher-Safety & Epidemiology-PS16647

Researcher-Safety & Epidemiology-PS16646


Eli Lilly Explains How it Handled Price Information in New TV Ads

Podcast Highlights 2018 Value-Based Care Summit

ISPOR Publication Synthesizes 'Good Practices' in HTA

Dimon: U.S. has Best System, Worst Outcomes

Industry Spotlight


Conferences Webinars
Investigator Initiated Sponsored Research Summit
    February 6-7, Cambridge, Massachusetts

Paying for Cures: Ensuring Patient Access and System Sustainability
    February 12, Washington, D.C.

MRC training workshop on Health Economics Analysis Plans
    February 14, Bristol, England

18th Annual International Publication Planning Meeting
    February 20-21, San Diego, California

AMCP Policy and Advocacy Focus Areas for 2019
    February 5

Patient Engagement in Drug Development: An Opportunity for Medical Affairs
    February 6

Clinical Statistics for Non-Statisticians
    February 27

Amplifying the Patient Voice: Policy Solutions for Improving Patient-Reported Measures in Oncology Value-Based Payment Programs
    February 28


Conference of the Week Webinar of the Week Job of the Week Link of the Week

Syndicated Reports White Papers
Innovative Drugs: Mapping the Pricing and Reimbursement Landscape

Orphan Drugs: European Payer Perspectives

Do Payers Really Want Pay-for-Performance?

Payer Engagement: Benchmarking Team Structure and Activity

Benchmarking Market Access Strategies for High-Cost Drugs and Biologics

Blockchain: Transformational Change for Pharma?

The Global Use of Medicine in 2019 and Outlook to 2023

Breaking Through the Hype of Real-World Evidence

Time to Market: Accelerating Market Access

Orphan Drugs in the United States

Charting Real World Data and Evidence – Activity and Capabilities (2018)

From Patent to Patient: Analyzing Access to Innovative Cancer Drugs


Special Thanks to Our Partners:
               Evidera   HealthCore  
      University of FL   Xcenda  OM1    Parexel   Jefferson
      Dymaxium   Precision Xtract    Pharmerit    eMax Health
      Sciformix   Evidence Partners    ICON    Truven